Polpharma Biologics Group Announces that the Biologics License Application (BLA) Submitted by its Joint Venture Bioeq for its Biosimilar Ranibizumab has Been Accepted for Review by the U.S. Food and Drug Administration (FDA)
Polpharma Biologics Group announces that its joint venture company with Santo Holding (Strüngmann Group), Bioeq, has received notification by the U.S. Food and Drug Administration (FDA) that the biologics license application (BLA) for its proposed biosimilar (formally also known as BQ201, FYB201, CHS-201) to Lucentis®, a blockbuster ophthalmological drug containing ranibizumab as active drug substance, has been accepted for review.
The FDA has assigned a target action date for the application for August 2022.
The reference product is a monoclonal anti-angiogenic antibody fragment (Fab) that has been approved to treat the "wet" type of age-related macular degeneration, a common form of age-related vision loss. Worldwide, at least 25 to 30 million people are affected by age-related macular degeneration. The launch of a biosimilar Ranibizumab can increase market competition, reduce cost and expand patient access with proven analytical and clinical similarity to the original product.
This file acceptance represents the most recent milestone for Bioeq`s ranibizumab biosimilar program and compliments marketing authorization applications submitted to EMA in June and UK MHRA in July this year.
Subject to the FDA`s approval, BQ201 will be exclusively commercialized by Coherus BioSciences, Inc. in the United States.
Dr Joerg Windisch, CEO of the Polpharma Biologics Group, commented on the achievements of the joint venture:
“This file acceptance is validation of the huge effort put in by the team at Bioeq and its partners to bring treatment choice and improved patient access to the US market. It creates real promise for those who suffer from debilitating vision loss, including age-related macular degeneration.”
- Lucentis® is a registered trademark of Genentech Inc.
Information for editors
About Ranibizumab biosimilar
Bioeq`s proposed ranibizumab biosimilar BQ201, previously designated as FYB201 (and also known as CHS-201), has been originally licensed from Formycon AG (FRA: FYB/ WKN A1EWVY), a leading German biosimilars company, and subsequently developed by Bioeq AG, a joint venture between Polpharma Biologics and Santo Holding AG (Strüngmann Group). Phase III clinical trials for FYB201 have clinically demonstrated that the efficacy of FYB201 in patients with nAMD is comparable to that of Lucentis®.
About biosimilars
Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and expand patient access. Biosimilars exhibit proven analytical and clinical similarity to their respective branded reference products.
About Polpharma Biologics Group
The Polpharma Biologics Group creates quality biosimilars with a passion to improve lives of patients. The group has built an extensive and growing pipeline of biosimilars to treat a number of medical conditions across major therapeutic areas. Several of these biosimilar assets have already been commercially partnered with the world’s largest biopharmaceutical companies.
The group operates a network of state-of-the-art development and manufacturing facilities across Europe, actively investing in technology, people and know-how, employing over 800 specialists from around the globe.
Learn more at www.polpharmabiologics.com
About Bioeq
Bioeq is a Swiss biopharmaceutical joint venture between the Polpharma Biologics Group and the Strüngmann Group. Bioeq develops, licenses and commercializes biosimilars.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211004005408/en/
Contact information
Joseph Reeds
Head of Marketing
M +447807832776
E joseph.reeds@polpharmabiologics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Revolutionize Brand Engagement: MSquared Puts Interoperability Center Stage in MLB’s Virtual Ballpark!26.9.2024 23:48:00 EEST | Press release
Solving the Interoperability Challenge MSquared’s demonstration is the first major showcase of how it has solved the technical challenges of metaverse interoperability. The integration of the Metaverse Markup Language (MML) lies at the heart of this success, offering a revolutionary way to define interactive 3D content that can seamlessly run across different virtual spaces and engines. Additionally, M² has developed a secure digital rights management and moderation system that allows IP owners and consumers to have appropriate protections as content moves freely between worlds. “MSquared has systematically overcome the challenges of interoperability - from ownership to standardized visualizations and secure asset storage,” said Rob Whitehead, Chief Product Officer of Improbable. “Our technology safeguards intellectual property and brand integrity across diverse virtual environments, ensuring seamless and secure experiences.” Elevate Your Brand in the Metaverse This milestone event in
Grid Dynamics Expands Global Footprint with JUXT Acquisition, Strengthening Expertise in Banking and Financial Services26.9.2024 23:05:00 EEST | Press release
Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) (Grid Dynamics), a leading provider of technology consulting, platform and product engineering, AI, and digital engagement services, today announces its acquisition of JUXT, a UK-based provider of software engineering services specializing in data-intensive information systems for banking and other financial institutions, with a particular focus on risk platforms, structured notes, equity derivatives, and financial reporting. With this acquisition, Grid Dynamics adds significant expertise and capabilities to better serve enterprise clients in the financial services industry. Founded in 2013, JUXT is known for delivering complex end-to-end solutions, from design and user experience, to deep functionality and ongoing managed services. Their specializations in mission-critical platforms and products for leading banks and financial institutions make them a strategically important addition to Grid Dynamics, especially as global demand for reliable
BM3EAC Corp. 2024 Semi-Annual Report26.9.2024 21:58:00 EEST | Press release
BM3EAC Corp. (the “Company”), a special purpose acquisition company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., today published its semi-annual report for the period 1 January 2024 to 30 June 2024. The semi-annual report can be downloaded from the Company’s website via the following link: https://www.BrigadeM3EAC.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER This announcement is not for distribution or release, directly or indirectly, and should not be distributed in or sent into, the United States, Australia, Canada, Japan, the Cayman Islands or South Africa or any other jurisdiction in which such distribution or release would be unlawful or would require registration or other measures. This announ
UCC Holding Ranked 42 nd in ENR’s Top International Contractors26.9.2024 21:32:00 EEST | Press release
Urbacon Holding, a leader in energy, concessions, and construction, announced its ranking as the 42nd top international contractor for 2024, according to Engineering News-Record (ENR). The company celebrated this achievement during the ConteQ Expo 2024 in Qatar, where it participated as the event's official sponsor. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240926450701/en/ UCC Holding Ranked 42nd in ENR’s Top International Contractors (Photo: AETOSWire) The event brought together UCC Holding’s Board of Directors and senior management, who emphasized the company’s ongoing efforts to integrate advanced construction technologies into its operations. During the expo, UCC Holding introduced three innovative construction methods: 3D construction printing, concrete modular construction, and steel structure modular construction. These technologies are already being incorporated into UCC’s future projects, including a series of
Sinopec Awarded Best Environmental Protection Case at First Sino-European Corporate ESG Best Practice Conference26.9.2024 20:06:00 EEST | Press release
The ESG case from China’s Sinopec, titled “Empowering Green Development, Co-Creating a Zero-Carbon Future,” stood out from dozens of entries and was awarded the Best Case in the Environmental Protection category at the first Sino-European Corporate ESG Best Practice Conference held in Frankfurt, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240926903754/en/ An ESG case from China’s Sinopec was awarded the Best Case in the Environmental Protection category at the first Sino-European Corporate ESG Best Practice Conference held in Frankfurt, Germany. (Photo: Business Wire) Walter Döring, Chairman of German World Market Leaders Association, on behalf of the event's organizing committee, announced the results. He stated, “Sinopec has demonstrated exceptional practical value in environmental protection. Through its comprehensive environmental management system and innovative technological means, as well as the use of cle
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom